Phase 4 Prostate Cancer Trial, Recruiting NCT06001619 Sponsor: Turku University Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Phase 4 Prostate Cancer Trial, Recruiting

NCT06001619
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed and dated a consent form agreeing to take part.
  • People who are able and willing to follow all study procedures and are available for the full duration of the study.

Who may not be able to join:

  • People who have ever had a fecal (stool) transplant.
  • People who have had a stomach or gut infection (gastroenteritis) within the last 3 months, or who still have symptoms from one.
  • People who have taken antibiotics within the last 3 months (although antibiotics taken specifically to prepare for a prostate biopsy may be an exception — confirm with trial site).
  • People who are unable or unwilling to follow the study procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +35823135925

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Turku University Hospital
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
31 October 2024

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Gut microbiota signature before 5-ARI therapy; Gut microbiota signature after 5-ARI therapy; Gut microbiota signature before ADT (LHRH antagonists).; Gut microbiota signature after ADT (LHRH antagonists).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov